BF
Beta Fund
Micro VCActiveBeta Fund is an early-stage venture fund focused on emerging high-tech and biotechnology companies.
22
Investments
2
Exits
$4.8B
AUM
9.1%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Beta Fund.
Investment Thesis & Strategy
Beta Fund invests in early-stage biotechnology and fintech companies, as well as venture capital firms, with a focus on emerging high-tech.
Investment Activity
Deals per year over the last 5 years
2
20171
20183
20191
20205
2021Portfolio Companies
Selected investments from their portfolio of 22 companies
G
GentiBio
Biotech · Series A, 2021
T
Tessera Therapeutics
Biotech · Series A, 2021
C
Cellino
Biotech · Series A, 2021
A
Aether Biomedical
Biotech · Seed, 2021
D
Deepcell
Biotech · Series A, 2021
K
Kytopen
Biotech · Series A, 2020
S
Sana Biotechnology
Biotech · Series A, 2019
C
Curi Bio
Biotech · Series A, 2019
L
Locus Biosciences
Biotech · Series A, 2019
V
Vaxcyte
Biotech · Series A, 2018
I
Inscripta
Biotech · Series B, 2017
P
Pliant Therapeutics
Biotech · Series A, 2017
Frequently Asked Questions
Beta Fund focuses on Seed, Series A stage investments.
Related Investors
Spray Venture Partners
Newton, United States · 28 deals
SV Angel
San Francisco, United States · 922 deals
Right Side Capital Management
San Francisco, United States · 894 deals
Kima Ventures
Paris, France · 565 deals
Alumni Ventures Group
Manchester, United States · 442 deals
FundersClub
San Francisco, United States · 425 deals